Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia and Statin Intolerance
Background Inability to tolerate statins because of muscle symptoms contributes to uncontrolled cholesterol levels and insufficient cardiovascular risk reduction. Bempedoic acid, a prodrug that is activated by a hepatic enzyme not present in skeletal muscle, inhibits ATP‐citrate lyase, an enzyme ups...
Main Authors: | Ulrich Laufs, Maciej Banach, G. B. John Mancini, Daniel Gaudet, LeAnne T. Bloedon, Lulu Ren Sterling, Stephanie Kelly, Erik S. G. Stroes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-04-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.118.011662 |
Similar Items
-
Efficacy and Safety of Bempedoic Acid in Patients With Hypercholesterolemia: Systematic Review and Meta‐Analysis of Randomized Controlled Trials
by: Alessandro Di Minno, et al.
Published: (2020-08-01) -
Inclisiran adjuvant therapy to statins for the use of hypercholesterolemia: a commentary
by: Laiba Imran Vohra, et al.
Published: (2023-07-01) -
Bempedoic acid for the treatment of dyslipidemia
by: Joel C Marrs, et al.
Published: (2020-08-01) -
Hypercholesterolemia and COVID-19: Statins for Lowering the Risk of Venous Thromboembolism
by: Alpo Vuorio, et al.
Published: (2021-10-01) -
Statin sensitive lipid-retinopathy in familial hypercholesterolemia
by: Aysha Salam, et al.
Published: (2013-01-01)